Join the Oncology Voice Network. Join for Free
Managed Care MSLs-Past, Present and Future
Managed Care MSL Health Plans Medical Science Liaison MSL Skills Integrated Delivery Networks

Managed Care MSLs-Past, Present and Future


Share This Article


Summary

In this episode, Todd Wandstrat delves into the intricate world of managed care and its intersection with the Medical Science Liaison (MSL) role. He offers a comprehensive overview of managed care's history, including health plans, PBMs, and integrated delivery networks. Todd shares insights into the evolving role of MSLs in this sector, highlighting the unique customer base and value proposition they bring. He discusses the necessary skills and career pathways for aspiring managed care MSLs, emphasizing the importance of presentation skills and resume building. The conversation also touches on navigating the MSL role during COVID, fostering KOL relationships, and the significance of internal collaboration and innovative thinking.

Check out my latest podcast with Todd Wandstrat, Sr Director of Field Based Medicine who discusses Managed Care MSLs… Past, Present and Future

Todd shares…

 The historical perspective of the Managed Care Market and the MSL
 What is a Managed Care MSL
 What skills are mandatory and how can an MSL transition
 What does the future look like for MSLs

Click for Source
Managed Care MSL, Health Plans, Medical Science Liaison, MSL Skills, Integrated Delivery Networks

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN